Acme United Corporation

Acme United Corporation (ACU) Market Cap

Acme United Corporation has a market capitalization of —.

No quote data available.

CEO: Walter C. Johnsen

Sector: Consumer Defensive

Industry: Household & Personal Products

IPO Date: 1980-03-17

Website: https://www.acmeunited.com

Acme United Corporation (ACU) - Company Information

Market Cap: -|Sector: Consumer Defensive

Company Profile

Acme United Corporation is a global supplier specializing in first aid, safety, cutting, sharpening, and measuring tools. Its products cater to a diverse clientele across educational institutions, households, corporate offices, hardware stores, sporting goods outlets, and industrial sectors throughout the United States, Canada, Europe, and other international markets. The company's extensive portfolio is distributed under several prominent brands. Westcott offers a broad array of items including scissors, shears, various knives, rulers, pencil sharpeners, paper trimmers, specialized safety cutters, lettering supplies, glue guns, and craft essentials. Cutting implements fall under the Clauss brand. For outdoor and tactical applications, Camillus features fixed-blade and folding knives, sight-cutting devices, and tactical tools. Anglers benefit from Cuda, which provides fishing tools and knives, protective cut- and puncture-resistant gloves, telescopic landing nets, net containment systems, and fishing gaffs. Precision sharpening solutions are supplied by DMT. In the health and safety segment, First Aid Only delivers comprehensive first aid kits and safety provisions. PhysiciansCare offers portable eyewash solutions and a range of over-the-counter medications, including aspirin, acetaminophen, and ibuprofen. Spill Magic addresses bodily fluid and general spill clean-up requirements. First Aid Central expands the first aid offerings with various kits, refills, and specialized safety supplies like CPR, burn, automotive, and emergency kits. Lastly, Med-Nap provides a selection of sanitary wipes, such as alcohol prep pads, alcohol wipes, benzalkonium chloride wipes, antiseptic wipes, castile soaps, and lens cleaning wipes. Acme United employs a multi-channel distribution strategy, selling directly and through independent manufacturer representatives to a vast network. This includes wholesale, contract, and retail stationery distributors, large office supply stores, school supply channels, industrial distributors, wholesale florists, mass market and e-commerce retailers, and hardware chains. A curated range of its products is also available for purchase on the company's official websites. Founded in 1867 as Acme Shear Company, the corporation was renamed Acme United Corporation in 1971 and is headquartered in Shelton, Connecticut.

Analyst Sentiment

50%
Hold

From 1 Active Polls

Consensus Target Matrix

Data feed parsing pending...

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$59.70
▲ +5.00% Upside
Low Target
$42.64
-25% Risk
Median Target
$58.00
2% Mid
High Target
$71.08
25% Max

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

Sentiment volume allocation data unavailable.

valuation & financial ratiosdetailed financials

Historical valuation matrix unavailable.

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 ACME UNITED CORP (ACU) — Investment Overview

🧩 Business Model Overview

ACME UNITED CORP designs and manufactures safety, first aid, and cutting instruments, then sells them through distributors and direct channels to institutional and consumer end markets. The value chain is anchored in (1) product development and specification (durability, usability, safety materials, packaging/labeling), (2) manufacturing execution across differentiated SKUs, and (3) distribution into recurring replenishment cycles—especially for safety and first aid items embedded in institutional procurement workflows (schools, industrial sites, and healthcare-adjacent buyers).

A key feature of the model is that many purchases are driven by established compliance and operational needs (stocking requirements, workplace safety programs, and standardized kit contents), which favors repeat ordering and lowers the friction of requalification versus purely convenience-driven consumer goods.

💰 Revenue Streams & Monetisation Model

Revenue is primarily transactional, derived from shipment of branded and private-label safety and cutting products. Monetisation relies on:

  • Institutional replenishment: Safety and first aid products tend to be reordered as inventories are consumed, creating repeat demand even though the revenue is not contract/subscription-based.
  • SKU mix and packaging economics: Margin performance is influenced by product mix (premium safety items versus commodity-like forms), packaging formats (kits, multipacks), and procurement/service levels required by institutional customers.
  • Channel and distributor relationships: Distributor ordering patterns and shelf/assortment placement can provide stability, with growth tied to winning incremental share within existing customer lists.

Overall profitability is driven by gross margin (product mix and input cost management) and operating leverage (smoothing manufacturing utilization and managing freight/overhead across SKU complexity).

🧠 Competitive Advantages & Market Positioning

ACU’s competitive positioning is best understood as a combination of switching costs and operational/qualification barriers, supported by product know-how and distribution reach.

  • Switching costs (institutional buyers): Safety and first aid items are frequently standardized in procurement catalogs. Changing approved SKUs can require requalification, which makes repeat replenishment more likely than for purely discretionary products.
  • Quality and specification discipline: Cutting and safety products compete on durability, ergonomics, and build quality—attributes that are tested during institutional selection and tend to favor incumbents with proven performance.
  • Distribution leverage: Access to distributors and established order channels improves fill rates and reduces procurement friction for customers.

COMPETITIVE BENCHMARKING (selected peers)

  • 3M: Broad safety and healthcare presence with strong brand equity; competes across many categories rather than specializing exclusively in ACU’s specific safety/first aid and cutting niches.
  • Medline Industries: Focused on distribution-intensive healthcare supply with extensive catalog breadth; often competes on procurement convenience and supply coverage, while ACU competes on differentiated product functionality and institutional fit.
  • Newell Brands / Fiskars: Strength in cutting instruments and consumer tools; competes primarily on consumer and tool-like segments, while ACU’s emphasis is on safety/first aid adjacency and institutional-ready SKU breadth.

Compared with these broader or distribution-led competitors, ACU’s differentiation is tied to product qualification within safety workflows and the ability to deliver differentiated SKUs reliably through established channels.

🚀 Multi-Year Growth Drivers

  • Workplace safety and first aid replenishment cycles: Growth is supported by ongoing emphasis on safety compliance and operational readiness, which structurally sustains demand for stocked safety supplies.
  • Institutional assortment expansion: Incremental category penetration within school/industrial and healthcare-adjacent accounts can expand volumes without requiring a new customer acquisition model.
  • Product mix and packaging innovation: Higher-value kits, multipacks, and upgraded safety instruments can lift average selling prices and improve gross margin through more favorable product economics.
  • Private label and channel participation: Private-label programs can increase throughput and leverage manufacturing capabilities, provided ACU maintains quality and cost competitiveness.
  • Supply chain resilience and service levels: Better lead times, fill rates, and SKU availability tend to matter in institutional purchasing; consistent execution supports repeat ordering and reduces lost sales.

⚠ Risk Factors to Monitor

  • Input cost and commodity exposure: Cutting instruments and many safety products depend on materials (metals, plastics, packaging components). Margin can compress if cost increases outpace pricing actions.
  • Inventory and working-capital dynamics: Distributor and channel inventory cycles can swing results; excess inventory can create markdown risk and cash conversion pressure.
  • Concentration and channel power: Large distributors and institutional buyers can exert pricing pressure and influence assortment decisions.
  • Regulatory and compliance changes: Safety and healthcare-adjacent products can face evolving labeling, packaging, and compliance requirements that increase costs or constrain product introductions.
  • Product liability and quality risks: Safety-focused products can generate claims; robust quality systems are essential to limiting downside.

📊 Valuation & Market View

The market typically values specialized consumer/industrial product companies using EV/EBITDA, P/S (when growth and margin durability are emphasized), and cash-flow-based metrics given the transactional nature of sales.

Key valuation drivers include:

  • Gross margin durability via product mix, pricing discipline, and input cost management.
  • Operating leverage from improved manufacturing utilization and disciplined overhead.
  • Working-capital efficiency, especially inventory turns and cash conversion as demand normalizes across channels.
  • Evidence of share gains through assortment expansion and repeat institutional ordering.

🔍 Investment Takeaway

ACME UNITED CORP presents a value-oriented thesis grounded in institutional switching costs, product qualification, and distribution leverage within safety/first aid and cutting instruments. The durability of demand from replenishment cycles, combined with the ability to improve margin through mix and operational execution, supports a constructive long-term view—provided that ACU maintains quality, manages input costs, and avoids working-capital strains during channel inventory shifts.


⚠ AI-generated — informational only. Validate using filings before investing.

Related Companies in Consumer Defensive

KENVUE INC (KVUE)

Consumer Defensive

$36.94B

Mkt Cap

BUNGE GLOBAL SA (BG)

Consumer Defensive

$20.41B

Mkt Cap

KEURIG DR PEPPER INC (KDP)

Consumer Defensive

$42.34B

Mkt Cap

LAMB WESTON HOLDINGS INC (LW)

Consumer Defensive

$7.22B

Mkt Cap

CHURCH AND DWIGHT INC (CHD)

Consumer Defensive

$23.41B

Mkt Cap

KRAFT HEINZ (KHC)

Consumer Defensive

$30.65B

Mkt Cap

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-06-30

"ACU reported Q2’26 revenue of $62.7m and net income of $5.1m (EPS $1.32). YoY, revenue declined from $54.0m in Q2’25 to $62.7m in Q2’26 (+16.1%), and net income rose from $4.8m (+6.2%). QoQ, revenue increased from $52.3m in Q1’26 to $62.7m in Q2’26 (+19.9%), while net income jumped from $1.0m to $5.1m (+412.0%). Profitability weakened across the last four quarters: gross margin eased slightly (about 41.0% in Q2’25 to ~39.7% in Q2’26), and operating margin compressed materially (11.8% in Q2’25 to ~3.3% in Q2’26). Despite higher top-line growth, the company’s profitability normalized downward versus earlier quarters, suggesting cost structure pressure or unfavorable mix. Operating cash flow in Q2’26 was positive but small ($0.10m) versus net income, driven by working-capital items; the cash flow profile appears volatile quarter to quarter. Balance sheet resilience looks mixed: total assets rose to ~$200.6m in Q2’26, but equity fell sharply (to ~$121m is lower relative to Q1’26’s ~116.7m/and the cash line is small), while total debt was ~$29.3m with net debt ~$24.2m. Total shareholder returns are supported by price momentum: the stock is up +14.9% over 1 year, with dividend yield shown near ~0% (no clear cash dividends in Q2’26), and no buyback data provided—so the return appears primarily price-driven."

Revenue Growth

Positive

Q2’26 revenue grew +19.9% QoQ ($52.3m → $62.7m) and +16.1% YoY ($54.0m → $62.7m), indicating a solid demand rebound despite a softer multi-quarter profitability backdrop.

Profitability

Neutral

Net income improved YoY (+6.2%) and surged QoQ (+412%), but margins contracted over the 4-quarter span: gross margin slipped from ~41.0% (Q2’25) to ~39.7% (Q2’26), and operating margin fell from ~11.8% to ~3.3%.

Cash Flow Quality

Caution

Q2’26 operating cash flow was positive but modest ($0.10m) versus net income ($5.1m), implying working-capital volatility. No dividends or buybacks were reported in Q2’26.

Leverage & Balance Sheet

Fair

Leverage appears manageable with total debt ~$29.3m and net debt ~$24.2m, and total assets increased to ~$200.6m. However, cash is relatively low in Q2’26 ($5.0k vs millions previously), and equity dynamics look unstable across quarters.

Shareholder Returns

Neutral

Price momentum is positive but not extreme: +14.9% over 1 year. Dividend yield is essentially near zero in the provided ratios, and there is no buyback evidence in the supplied data.

Analyst Sentiment & Valuation

Positive

No price target was provided. Valuation ratios are inconsistent across quarters, but the stock’s positive 6m/1y performance suggests current sentiment has improved.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

RevenueEarningsP/E RatioSharesDebtMargin %

Fundamentals Overview

Loading fundamentals overview...

ACU delivered a solid Q2 2026 turnaround in profitability and margin quality, led by MyMedic mix and improving core demand. Net sales rose 16% to $63.0M and EPS increased 5% to $1.22, with gross margin expanding 160 bps to 42.6%—explicitly attributed to higher-margin MyMedic. Tariffs remain the key financial timing risk: management cited a ~100 bps U.S. margin drag in Q2 versus ~150 bps in Q1 and expects a ~1% gross margin recovery as high-tariff inventory sells down over the next two quarters. SG&A rose as expected because MyMedic requires heavy advertising/marketing. Operationally, ACU is focused on scaling Spill Magic capacity via automation in a newly moved-in Tennessee facility and progressing MedNap regulatory compliance for potential U.S. hospital channel expansion by year-end. Demand signals are mixed but not deteriorating: management reported no MyMedic weakness and emphasized that Westcott promotional activity has resumed, with growth driven mostly by volume.

AI IconGrowth Catalysts

  • MyMedic gross margin and operating leverage ramp; management expects stronger profitability in Q4 and into Q1 as ad/marketing investment normalizes and inventory sourced earlier under favorable pricing is sold
  • First Aid and Medical business growth in the U.S. (+10%); resumption of mass retail promotions driving additional sales
  • Spill Magic capacity expansion: Tennessee plant is now in the new 12-acre, 78k sq ft owned facility; automation installed 'unlike any of its competitors' to support sustained throughput
  • MedNap facility investment in Florida: regulatory compliance upgrades progressing; targeted completion by year-end to enable future U.S. hospital certifications
  • MyMedic distribution expansion planned: presentations to large mass-market retailers and industrial distributors; shifting MyMedic from mostly DTC toward retail/wholesale mix

Business Development

  • MyMedic acquisition (closed/integrated January 2026); management highlights direct-to-consumer focus and high-margin product portfolio
  • Government/hospital systems channel expansion discussed via MedNap certification work (no named customer provided)
  • MyMedic planned placements with large mass-market retailers and industrial distributors (no named partners provided)
  • Sales channels referenced that include Walmart, Granger, and Fastenal as competitive wins (particularly Westcott, but not formal partnership agreements)

AI IconFinancial Highlights

  • Net sales: $63.0M vs $54.0M prior-year quarter (+16%); Ex-MyMedic sales +8%
  • EPS: $1.22 (+5% YoY); net income $5.1M vs $4.8M (+6% YoY)
  • Six-months ended 6/30/2026 net sales $115M vs $100M (+15%); Ex-MyMedic sales +7%
  • Gross margin: 42.6% in Q2 2026 vs 41.0% in Q2 2025 (+160 bps) driven by higher-margin MyMedic mix
  • U.S. gross margin headwind from tariffs: reduced by ~100 bps in Q2; Q1 headwind cited as ~150 bps (management discussion); tariff impact expected to lessen over next two quarters as high-tariff inventory is worked down
  • U.S. gross margin uplift expected mechanically: management said 'if we reduced our normal gross margin by 1%, you can picture…we will recover that 1%' as tariff-locked inventory is sold
  • SG&A: $19.9M (32% of sales) vs $15.8M (29% of sales) YoY; higher SG&A due to MyMedic advertising and marketing

AI IconCapital Funding

  • Net debt: $27.3M at 06/30/2026 vs $22.8M at 06/30/2025 (+$4.5M)
  • Cash return/capital actions over trailing 12 months: $14.0M paid for MyMedic asset acquisition; dividends of ~$2.4M; Germany cutting/sharpening product line purchase for $1.6M
  • Free cash flow generated: ~$15M over the trailing 12 months (no buyback disclosed; no repurchase amounts stated)

AI IconStrategy & Ops

  • MyMedic integration focus: grow core direct-to-consumer business while expanding retail offering; manage cost of goods via sourcing team improvements and consolidating freight with other ACU shipments
  • Freight and internal efficiency: consolidating shipments to reduce costs; eliminating duplicate corporate functions
  • Inventory buffering strategy: when Iran war began, placed orders for ~$10M extra inventory to buffer potential shortages/cost increases; management says stock remains in place
  • Automation capex: Spill Magic moved into owned Tennessee facility and is adding automation 'unlike any of its competitors'
  • Smart compliance software: next generation automatically scans first-aid kit contents and generates replenishment orders via internet; in final stages and 'about to be going out to early distributors'
  • Regulatory/credentialing: MedNap Florida compliance upgrades to pursue U.S. hospital market certification; target completion by year-end

AI IconMarket Outlook

  • Near-term: continued growth of First Aid and Medical, resumption of promotional retail activity with Westcott cutting tools, improving MyMedic profitability, and gross margin expansion as high-tariff products are replaced by lower-cost ones
  • Gross margin/tariff cadence: tariff-related gross margin impact expected to lessen over 'the next 2 quarters' as tariff rates declined (noted declines in Nov 2025 and Feb 2026)

AI IconRisks & Headwinds

  • Tariffs: continued volatility affecting product costs and margins; inventory capitalization of tariff costs in prior periods is driving earnings impact with timing shifts across quarters
  • Freight/cost inflation: higher bunker fuel costs and online delivery costs; weaker USD vs Chinese currency is a headwind for China-imported items
  • Consumer macro pressure: management acknowledged customers have less disposable budget; however they reported no observed weakness in MyMedic so far
  • Regulatory certification risk: MedNap hospital/U.S. certification completion depends on compliance work (management says progressing well, targeted by year-end)

Q&A: Analyst Interest

  • Gross margin drivers and tariff normalization: Management linked Q2 gross margin lift to higher-margin MyMedic mix and noted tariff effects reduced U.S. margins ~100 bps in Q2 versus ~150 bps in Q1. As tariff inventory sells through over the next two quarters, they expect ~1% gross margin recovery, offsetting freight/fuel and FX headwinds.
  • Demand durability amid macro and consumer discretion: Management asked analysts to consider MyMedic as essential with strong consumer behavior so far; they said MyMedic sales are 'right on plan' and 'not seeing weakness.' They cited robust Europe performance and continued buying in Westcott/first aid as validation despite inflation concerns and smaller baskets from retailers.
  • Unit vs price contribution in Westcott and Canada weakness drivers: For Westcott, management said the Q2 growth was 'most of it…volume,' with pricing increases not evenly transferable across SKUs. For Canada, management attributed uneven performance to stronger First Aid Central and weaker Westcott tied to economy sluggishness; they said tariff impact is limited for their Canadian-shipped SKUs.

Sentiment: MIXED

Note: This summary was synthesized by AI from the ACU Q2 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

Loading financial data and tables...
© 2026 Stock Market Info — Acme United Corporation (ACU) Financial Profile